{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T07:15:50Z","timestamp":1776755750411,"version":"3.51.2"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Digit. Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Current methods of measuring disease progression of neurodegenerative disorders, including Parkinson's disease (PD), largely rely on composite clinical rating scales, which are prone to subjective biases and lack the sensitivity to detect progression signals in a timely manner. Digital health technology (DHT)-derived measures offer potential solutions to provide objective, precise, and sensitive measures that address these limitations. However, the complexity of DHT datasets and the potential to derive numerous digital features that were not previously possible to measure pose challenges, including in selection of the most important digital features and construction of composite digital biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We present a comprehensive machine learning based framework to construct composite digital biomarkers for progression tracking. This framework consists of a marginal (univariate) digital feature screening, a univariate association test, digital feature selection, and subsequent construction of composite (multivariate) digital disease progression biomarkers using Penalized Generalized Estimating Equations (PGEE). As an illustrative example, we applied this framework to data collected from a PD longitudinal observational study. The data consisted of Opal\u2122 sensor-based movement measurements and MDS-UPDRS Part III scores collected at 3-month intervals for 2 years in 30 PD and 10 healthy control participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In our illustrative example, 77 out of 235 digital features from the study passed univariate feature screening, with 11 features selected by PGEE to include in construction of the composite digital measure. Compared to MDS-UPDRS Part III, the composite digital measure exhibited a smoother and more significant increasing trend over time in PD groups with less variability, indicating improved ability for tracking disease progression. This composite digital measure also demonstrated the ability to classify between\n                      <jats:italic>de novo<\/jats:italic>\n                      PD and healthy control groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Measures from DHTs show promise in tracking neurodegenerative disease progression with increased sensitivity and reduced variability as compared to traditional clinical scores. Herein, we present a novel framework and methodology to construct composite digital measure of disease progression from high-dimensional DHT datasets, which may have utility in accelerating the development and application of composite digital biomarkers in drug development.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fdgth.2024.1500811","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T01:13:50Z","timestamp":1736471630000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["A novel machine learning based framework for developing composite digital biomarkers of disease progression"],"prefix":"10.3389","volume":"6","author":[{"given":"Song","family":"Zhai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andy","family":"Liaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Svetnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J.","family":"FitzGerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chrystalina A.","family":"Antoniades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Holder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marissa F.","family":"Dockendorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement disorder society-sponsored revision of the unified Parkinson\u2019s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Movement Disord"},{"key":"B2","article-title":"Qualification Opinion on Dopamine Transporter Imaging as an Enrichment Biomarker for Parkinson\u2019s Disease Clinical Trials in Patients with Early Parkinsonian Symptoms. European Medicines Agency:EMA\/CHMP SAWP\/765041\/2017","year":"2018"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/mds.25684","article-title":"Objective features of balance and gait for Parkinson\u2019s disease using body-worn sensors","volume":"28","author":"Horak","year":"2013","journal-title":"Mov Disord"},{"key":"B4","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.parkreldis.2014.02.022","article-title":"Clinician versus machine: reliability and responsiveness of motor endpoints in Parkinson\u2019s disease","volume":"20","author":"Heldman","year":"2014","journal-title":"Parkinsonism Relat D"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e16178","DOI":"10.2196\/16178","article-title":"Leveraging smart health technology to empower patients and family caregivers in managing cancer pain: protocol for a feasibility study","volume":"8","author":"LeBaron","year":"2019","journal-title":"Jmir Res Protoc"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e19068","DOI":"10.2196\/19068","article-title":"Real-life gait performance as a digital biomarker for motor fluctuations: the Parkinson@home validation study","volume":"22","author":"Evers","year":"2020","journal-title":"J Med Internet Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41746-019-0214-x","article-title":"Mhealth and wearable technology should replace motor diaries to track motor fluctuations in Parkinson\u2019s disease","volume":"3","author":"Erb","year":"2020","journal-title":"NPJ Digitl Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41746-019-0217-7","article-title":"Development of digital biomarkers for resting tremor and bradykinesia using a wrist-worn wearable device","volume":"3","author":"Mahadevan","year":"2020","journal-title":"NPJ Digit Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41746-022-00607-8","article-title":"Virtual exam for Parkinson\u2019s disease enables frequent and reliable remote measurements of motor function","volume":"5","author":"Burq","year":"2022","journal-title":"NPJ Digit Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"705407","DOI":"10.3389\/fneur.2021.705407","article-title":"A phase II study to evaluate the safety and efficacy of prasinezumab in early Parkinson\u2019s disease (PASADENA): rationale, design, and baseline data","volume":"12","author":"Pagano","year":"2021","journal-title":"Front Neurol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e16415","DOI":"10.1016\/j.heliyon.2023.e16415","article-title":"Antiparkinsonian medication masks motor signal progression in de novo patients","volume":"9","author":"Brzezicki","year":"2023","journal-title":"Heliyon"},{"key":"B12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1056\/NEJMoa2202867","article-title":"Trial of prasinezumab in early-stage Parkinson\u2019s disease","volume":"387","author":"Pagano","year":"2022","journal-title":"New Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"S190","DOI":"10.14283\/jpad.2022.97","article-title":"Validation of an objective, SpeechBased object content score for measuring disease progression in AD","volume":"9","author":"Robin","year":"2022","journal-title":"J Prev Alzheimer\u2019s Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"eadc9669","DOI":"10.1126\/scitranslmed.adc9669","article-title":"Monitoring gait at home with radio waves in Parkinson\u2019s disease: a marker of severity, progression, and medication response","volume":"14","author":"Liu","year":"2022","journal-title":"Sci Transl Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1038\/s41591-022-01932-x","article-title":"Artificial intelligence-enabled detection and assessment of Parkinson\u2019s disease using nocturnal breathing signals","volume":"28","author":"Yang","year":"2022","journal-title":"Nat Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41591-022-02159-6","article-title":"A wearable motion capture suit and machine learning predict disease progression in Friedreich\u2019s ataxia","volume":"29","author":"Kadirvelu","year":"2023","journal-title":"Nat Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41591-022-02045-1","article-title":"Wearable full-body motion tracking of activities of daily living predicts disease trajectory in Duchenne muscular dystrophy","volume":"29","author":"Ricotti","year":"2023","journal-title":"Nat Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41746-023-00778-y","article-title":"Wearable device and smartphone data quantify ALS progression and may provide novel outcome measures","volume":"6","author":"Johnson","year":"2023","journal-title":"NPJ Digit Med"},{"key":"B19","article-title":"A digital motor score for sensitive detection of disease progression in early manifest Huntington's disease","author":"Giboin","year":"2023"},{"key":"B20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000525255","article-title":"Quantifying the benefits of digital biomarkers and technology-based study endpoints in clinical trials: project moneyball","volume":"6","author":"Mori","year":"2022","journal-title":"Digit Biomark"},{"key":"B21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41531-024-00721-2","article-title":"Using a smartwatch and smartphone to assess early Parkinson\u2019s disease in the WATCH-PD study over 12 months","volume":"10","author":"Adams","year":"2024","journal-title":"NPJ Park.\u2019s Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s43856-024-00481-3","article-title":"Improved measurement of disease progression in people living with early Parkinson\u2019s disease using digital health technologies","volume":"4","author":"Czech","year":"2024","journal-title":"Commun. Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.icte.2016.10.005","article-title":"Gait and tremor assessment for patients with Parkinson\u2019s disease using wearable sensors","volume":"2","author":"Perumal","year":"2016","journal-title":"Ict Express"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0157077","DOI":"10.1371\/journal.pone.0157077","article-title":"Predictive big data analytics: a study of Parkinson\u2019s disease using large, complex, heterogeneous, incongruent, multi-source and incomplete observations","volume":"11","author":"Dinov","year":"2016","journal-title":"PLoS One"},{"key":"B25","first-page":"23","article-title":"Prediction of Parkinson disease using gait signals","author":"Alaskar","year":"2018"},{"key":"B26","doi-asserted-by":"publisher","first-page":"7129","DOI":"10.1038\/s41598-018-24783-4","article-title":"Model-based and model-free machine learning techniques for diagnostic prediction and classification of clinical outcomes in Parkinson\u2019s disease","volume":"8","author":"Gao","year":"2018","journal-title":"Sci Rep"},{"key":"B27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fict.2019.00010","article-title":"Application of machine learning in a Parkinson\u2019s disease digital biomarker dataset using neural network construction (NNC) methodology discriminates patient motor Status","volume":"6","author":"Tsoulos","year":"2019","journal-title":"Frontiers Ict"},{"key":"B28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41531-022-00439-z","article-title":"Identification and prediction of Parkinson\u2019s disease subtypes and progression using machine learning in two cohorts","volume":"8","author":"Dadu","year":"2022","journal-title":"NPJ Park.\u2019s Dis"},{"key":"B29","article-title":"Prasinezumab reduced progression of Parkinson\u2019s disease motor features measured by roche PD Mobile application v2 sensor features: PASADENA phase II part 1 [abstract]","volume":"36","author":"Taylor","year":"2021","journal-title":"Mov Disord"},{"key":"B30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41531-023-00581-2","article-title":"Identification of motor progression in Parkinson\u2019s disease using wearable sensors and machine learning","volume":"9","author":"Sotirakis","year":"2023","journal-title":"NPJ Park.\u2019s Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"B32","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1541-0420.2011.01678.x","article-title":"Penalized generalized estimating equations for high-dimensional longitudinal data analysis","volume":"68","author":"Wang","year":"2012","journal-title":"Biometrics"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e000214","DOI":"10.1136\/bmjno-2021-000214","article-title":"Longitudinal changes of early motor and cognitive symptoms in progressive supranuclear palsy: the OxQUIP study","volume":"4","author":"Pereira","year":"2022","journal-title":"BMJ Neurology Open"},{"key":"B34","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-540-25966-4_33","article-title":"Application of breiman\u2019s random forest to modeling structure-activity relationships of pharmaceutical molecules","volume-title":"Multiple Classifier Systems. MCS 2004. Lecture Notes in Computer Science, vol 3077","author":"Svetnik","year":"2004"},{"key":"B35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1136\/jnnp.2009.173740","article-title":"The instrumented timed up and go test: potential outcome measure for disease modifying therapies in Parkinson\u2019s disease","volume":"81","author":"Zampieri","year":"2010","journal-title":"J Neurology Neurosurg Psychiatry"},{"key":"B36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ibror.2018.06.002","article-title":"Quantifying turning behavior and gait in Parkinson\u2019s disease using mobile technology","volume":"5","author":"Koop","year":"2018","journal-title":"Ibro Reports"},{"key":"B37","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1080\/09593985.2020.1774948","article-title":"The figure-of-8 walk test used to detect the loss of motor skill in walking among persons with Parkinson\u2019s disease","volume":"38","author":"Lowry","year":"2022","journal-title":"Physiother Theory Pract"},{"key":"B38","doi-asserted-by":"publisher","first-page":"12081","DOI":"10.1038\/s41598-022-15874-4","article-title":"Reliability and validity of the Roche PD Mobile application for remote monitoring of early Parkinson\u2019s disease","volume":"12","author":"Lipsmeier","year":"2022","journal-title":"Sci Rep-uk"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1080\/09638280701829938","article-title":"Dysfunctional turning in Parkinson\u2019s disease","volume":"30","author":"Stack","year":"2008","journal-title":"Disabil Rehabil"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.3109\/09638288.2014.961661","article-title":"Narrative review of turning deficits in people with Parkinson\u2019s disease","volume":"37","author":"Hulbert","year":"2014","journal-title":"Disabil Rehabil"},{"key":"B41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00221-008-1446-1","article-title":"Sudden turn during walking is impaired in people with Parkinson\u2019s disease","volume":"190","author":"Mak","year":"2008","journal-title":"Exp Brain Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3233\/JPD-202403","article-title":"Relationship between brain volumes and objective balance and gait measures in Parkinson\u2019s disease","volume":"12","author":"Ragothaman","year":"2021","journal-title":"J Park.\u2019s Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12883-019-1394-3","article-title":"The personalized Parkinson project: examining disease progression through broad biomarkers in early Parkinson\u2019s disease","volume":"19","author":"Bloem","year":"2019","journal-title":"BMC Neurol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"6831","DOI":"10.3390\/s22186831","article-title":"Deep learning for daily monitoring of Parkinson\u2019s disease outside the clinic using wearable sensors","volume":"22","author":"Atri","year":"2022","journal-title":"Sensors"},{"key":"B45","doi-asserted-by":"publisher","first-page":"37622","DOI":"10.1109\/ACCESS.2021.3062484","article-title":"Machine learning and deep learning approaches for brain disease diagnosis: principles and recent advances","volume":"9","author":"Khan","year":"2021","journal-title":"IEEE Access"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1214\/21-SS133","article-title":"Interpretable machine learning: fundamental principles and 10 grand challenges","volume":"16","author":"Rudin","year":"2022","journal-title":"Stat Surv"},{"key":"B47","article-title":"Good machine learning practice for medical device development: guiding principles (2021)","year":""}],"container-title":["Frontiers in Digital Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2024.1500811\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T01:13:53Z","timestamp":1736471633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2024.1500811\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":47,"alternative-id":["10.3389\/fdgth.2024.1500811"],"URL":"https:\/\/doi.org\/10.3389\/fdgth.2024.1500811","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.09.23.24313737","asserted-by":"object"}]},"ISSN":["2673-253X"],"issn-type":[{"value":"2673-253X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]},"article-number":"1500811"}}